Literature DB >> 25787078

Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system.

Yuka Kobayashi1, Norikazu Kiguchi1, Yohji Fukazawa1, Fumihiro Saika1, Takehiko Maeda2, Shiroh Kishioka3.   

Abstract

Peripheral neuroinflammation caused by activated immune cells can provoke neuropathic pain. Herein, we investigate the actions of macrophages and T cells through glucocorticoid-induced tumor neurosis factor receptor ligand (GITRL) and its receptor (GITR) in neuropathic pain. After partial sciatic nerve ligation (PSL) in enhanced green fluorescent protein (eGFP) chimeric mice generated by the transplantation of eGFP(+) bone marrow cells, eGFP(+) macrophages, and T cells markedly migrated to the injured site after PSL. Administration of agents to deplete macrophages (liposome-clodronate and Clophosome-A(TM)) or T cells (anti-CD4 antibody and FTY720) could suppress PSL-induced thermal hyperalgesia and tactile allodynia. The expression levels of co-stimulatory molecules GITRL and GITR were increased on infiltrating macrophages and T cells, respectively. The perineural injection of a GITRL neutralizing antibody that could inhibit the function of the GITRL-GITR pathway attenuated PSL-induced neuropathic pain. Additionally, the induction of inflammatory cytokines and the accumulation of GITR(+) T cells in the injured SCN were abrogated after macrophage depletion by Clophosome-A(TM). In conclusion, GITRL expressed on macrophages drives cytokine release and T cell activation, resulting in neuropathic pain via GITR-dependent actions. The GITRL-GITR pathway might represent a novel target for the treatment of neuropathic pain.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  bone marrow; cell-cell interaction; chronic pain; co-stimulatory molecules; cytokine; neurodegeneration; neuroinflammation; peripheral sensitization

Mesh:

Substances:

Year:  2015        PMID: 25787078      PMCID: PMC4432281          DOI: 10.1074/jbc.M115.636506

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  The neuropathic pain triad: neurons, immune cells and glia.

Authors:  Joachim Scholz; Clifford J Woolf
Journal:  Nat Neurosci       Date:  2007-11       Impact factor: 24.884

Review 2.  Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells.

Authors:  Bruce M Hall; Nirupama D Verma; Giang T Tran; Suzanne J Hodgkinson
Journal:  Curr Opin Immunol       Date:  2011-08-11       Impact factor: 7.486

Review 3.  Mechanisms of neuropathic pain.

Authors:  James N Campbell; Richard A Meyer
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

Review 4.  New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression.

Authors:  Scott M Steward-Tharp; Yun-jeong Song; Richard M Siegel; John J O'Shea
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

5.  T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression.

Authors:  Christoph Kleinschnitz; Harald H Hofstetter; Sven G Meuth; Stefan Braeuninger; Claudia Sommer; Guido Stoll
Journal:  Exp Neurol       Date:  2006-05-03       Impact factor: 5.330

Review 6.  Pathophysiology of peripheral neuropathic pain: immune cells and molecules.

Authors:  Michael A Thacker; Anna K Clark; Fabien Marchand; Stephen B McMahon
Journal:  Anesth Analg       Date:  2007-09       Impact factor: 5.108

7.  Peri-sciatic administration of recombinant rat TNF-alpha induces mechanical allodynia via upregulation of TNF-alpha in dorsal root ganglia and in spinal dorsal horn: the role of NF-kappa B pathway.

Authors:  Xu-Hong Wei; Ying Zang; Chang-You Wu; Ji-Tian Xu; Wen-Jun Xin; Xian-Guo Liu
Journal:  Exp Neurol       Date:  2007-03-23       Impact factor: 5.330

8.  Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury.

Authors:  Giuseppe Nocentini; Salvatore Cuzzocrea; Tiziana Genovese; Rodolfo Bianchini; Emanuela Mazzon; Simona Ronchetti; Emanuela Esposito; Di Paola Rosanna; Placido Bramanti; Carlo Riccardi
Journal:  Mol Pharmacol       Date:  2008-03-05       Impact factor: 4.436

9.  Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target.

Authors:  Sylvaine You; Lynn Poulton; Steve Cobbold; Chih-Pin Liu; Michael Rosenzweig; Douglas Ringler; Wen-Hui Lee; Berta Segovia; Jean-François Bach; Herman Waldmann; Lucienne Chatenoud
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

10.  Antinociceptive activity of the S1P-receptor agonist FTY720.

Authors:  Ovidiu Coste; Sandra Pierre; Claudiu Marian; Christian Brenneis; Carlo Angioni; Helmut Schmidt; Laura Popp; Gerd Geisslinger; Klaus Scholich
Journal:  J Cell Mol Med       Date:  2008-06       Impact factor: 5.310

View more
  31 in total

1.  Differential Tolerance to FTY720-Induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of Sphingosine-1-Phosphate Receptor Adaptation.

Authors:  Laura J Sim-Selley; Jenny L Wilkerson; James J Burston; Kurt F Hauser; Virginia McLane; Sandra P Welch; Aron H Lichtman; Dana E Selley
Journal:  J Pharmacol Exp Ther       Date:  2018-06-26       Impact factor: 4.030

Review 2.  Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation.

Authors:  Felipe A Pinho-Ribeiro; Waldiceu A Verri; Isaac M Chiu
Journal:  Trends Immunol       Date:  2016-10-25       Impact factor: 16.687

Review 3.  Immunity and pain in the eye: focus on the ocular surface.

Authors:  Romina Mayra Lasagni Vitar; Filippo Bonelli; Paolo Rama; Giulio Ferrari
Journal:  Clin Exp Immunol       Date:  2022-04-04       Impact factor: 4.330

4.  Targeting Neuroimmune Interactions in Diabetic Neuropathy with Nanomedicine.

Authors:  Mihály Balogh; Jelena M Janjic; Andrew J Shepherd
Journal:  Antioxid Redox Signal       Date:  2022-01       Impact factor: 8.401

Review 5.  Potential Neuroimmune Interaction in Chronic Pain: A Review on Immune Cells in Peripheral and Central Sensitization.

Authors:  Jia-Xuan Yang; Hong-Fei Wang; Ji-Zhun Chen; Han-Yu Li; Ji-Chen Hu; An-An Yu; Jun-Jun Wen; Si-Jia Chen; Wei-Dong Lai; Song Wang; Yan Jin; Jie Yu
Journal:  Front Pain Res (Lausanne)       Date:  2022-07-04

6.  Generation of Novel Diagnostic and Therapeutic Exosomes to Detect and Deplete Protumorigenic M2 Macrophages.

Authors:  Mohammad Harun Rashid; Thaiz F Borin; Roxan Ara; Ahmet Alptekin; Yutao Liu; Ali S Arbab
Journal:  Adv Ther (Weinh)       Date:  2020-05-04

7.  Treatment-Induced Neuropathy in Diabetes (TIND)-Developing a Disease Model in Type 1 Diabetic Rats.

Authors:  Petra Baum; Severin Koj; Nora Klöting; Matthias Blüher; Joseph Classen; Sabine Paeschke; Martin Gericke; Klaus V Toyka; Marcin Nowicki; Joanna Kosacka
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

8.  T cell transgressions: Tales of T cell form and function in diverse disease states.

Authors:  Kevin M Harris; Madison A Clements; Andrew J Kwilasz; Linda R Watkins
Journal:  Int Rev Immunol       Date:  2021-06-21       Impact factor: 5.078

9.  Electroacupuncture Relieves Pain and Attenuates Inflammation Progression Through Inducing IL-10 Production in CFA-Induced Mice.

Authors:  Mei-Ling Yu; Rui-de Wei; Tao Zhang; Jun-Meng Wang; Yu Cheng; Fen-Fen Qin; Shu-Ping Fu; Zhi-Gang Lu; Sheng-Feng Lu
Journal:  Inflammation       Date:  2020-08       Impact factor: 4.657

Review 10.  The Emerging Role of HMGB1 in Neuropathic Pain: A Potential Therapeutic Target for Neuroinflammation.

Authors:  Wenbin Wan; Lan Cao; Ramin Khanabdali; Bill Kalionis; Xiantao Tai; Shijin Xia
Journal:  J Immunol Res       Date:  2016-05-18       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.